- Home
- PROK vs STEM Comparison
PROK vs STEM Comparison
Compare PROK & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- STEM
- Stock Information
- Founded
- PROK 2015
- STEM 2009
- Country
- PROK United States
- STEM United States
- Employees
- PROK N/A
- STEM N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- STEM Computer Software: Prepackaged Software
- Sector
- PROK Health Care
- STEM Technology
- Exchange
- PROK Nasdaq
- STEM Nasdaq
- Market Cap
- PROK 85.5M
- STEM 75.7M
- IPO Year
- PROK N/A
- STEM N/A
- Fundamental
- Price
- PROK $4.74
- STEM $8.77
- Analyst Decision
- PROK Buy
- STEM Hold
- Analyst Count
- PROK 4
- STEM 9
- Target Price
- PROK $5.33
- STEM $23.38
- AVG Volume (30 Days)
- PROK 33.1M
- STEM 449.4K
- Earning Date
- PROK 08-08-2025
- STEM 08-07-2025
- Dividend Yield
- PROK N/A
- STEM N/A
- EPS Growth
- PROK N/A
- STEM N/A
- EPS
- PROK N/A
- STEM N/A
- Revenue
- PROK $306,000.00
- STEM $151,627,000.00
- Revenue This Year
- PROK $54.34
- STEM $5.72
- Revenue Next Year
- PROK N/A
- STEM $19.61
- P/E Ratio
- PROK N/A
- STEM N/A
- Revenue Growth
- PROK N/A
- STEM N/A
- 52 Week Low
- PROK $0.46
- STEM $5.81
- 52 Week High
- PROK $7.13
- STEM $33.60
- Technical
- Relative Strength Index (RSI)
- PROK 92.14
- STEM 51.05
- Support Level
- PROK $0.54
- STEM $6.04
- Resistance Level
- PROK $7.13
- STEM $9.60
- Average True Range (ATR)
- PROK 0.62
- STEM 1.17
- MACD
- PROK 0.47
- STEM 0.25
- Stochastic Oscillator
- PROK 68.59
- STEM 73.80
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.